journal article·2025-11-26

Carbonic Anhydrase Targeting Polymer with Enhanced Intracellular Protein Delivery and Tumor Penetration for Cancer Therapy

Yanwen Li, Jing Feng, Hui Wang, Yiyun Cheng, Jia Lv

Nano Letters· Volume 25· Issue 47
Publisher page

Abstract

Protein-based therapeutics demonstrate significant potential for cancer treatment, but their clinical application is often limited by poor tumor penetration, inefficient cellular uptake, and diminished activity in the acidic tumor microenvironment (TME). To overcome these challenges, we developed a cationic polymer modified with benzenesulfonamide groups as a protein delivery vehicle. This modification enhances protein binding through hydrophobic and hydrogen-bonding interactions, promotes cellular uptake and endosomal escape, and inhibits carbonic anhydrase IX in cancer cells to neutralize the acidic TME and suppress tumor growth. Furthermore, the polymer targets the Golgi apparatus, enabling an intercellular transfer pathway that improves the deep tumor penetration. In B16 melanoma-bearing mice, the engineered polymer facilitated efficient delivery of α-chymotrypsin to tumor sites, resulting in a significant inhibition of tumor growth. This work presents a versatile protein delivery strategy that combines TME modulation with organelle-specific trafficking for enhanced tumor targeting.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Enzyme function and inhibition · Cancer Research and Treatments · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

South China Advanced Institute for Soft Matter Science and Technology, Guangdong Provincial Key Laboratory of Functional and Intelligent Hybrid Materials and Devices, School of Emergent Soft Matter

South China University of Technology

Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences

East China Normal University

Joint Center for Translational Medicine, Shanghai Fifth People’s Hospital, Fudan University and School of Life Science

Funding

National Key Research and Development Program of China · Natural Science Foundation of Sichuan Province · National Natural Science Foundation of China

References (70)

Show source-provided references
1. 10.3390/antib903003410.3390/antib9030034 ↗
2. 10.1038/nbt113710.1038/nbt1137 ↗
3. 10.1038/s41467-020-17670-y10.1038/s41467-020-17670-y ↗
4. 10.1038/s12276-018-0191-110.1038/s12276-018-0191-1 ↗
5. 10.1038/nrc250710.1038/nrc2507 ↗
6. 10.1038/nri196110.1038/nri1961 ↗
7. 10.1038/s41551-021-00698-w10.1038/s41551-021-00698-w ↗
8. 10.1016/j.biomaterials.2019.11935810.1016/j.biomaterials.2019.119358 ↗
9. 10.1002/adma.20190279110.1002/adma.201902791 ↗
10. 10.1016/j.biomaterials.2017.04.03610.1016/j.biomaterials.2017.04.036 ↗
11. 10.1021/accountsmr.4c0014910.1021/accountsmr.4c00149 ↗
12. 10.1002/advs.20250084410.1002/advs.202500844 ↗
13. 10.1073/pnas.152024411310.1073/pnas.1520244113 ↗
14. 10.1038/nbt.308110.1038/nbt.3081 ↗
15. 10.1016/j.biomaterials.2023.12200010.1016/j.biomaterials.2023.122000 ↗
16. 10.1002/ange.20190169910.1002/ange.201901699 ↗
17. 10.1021/acs.nanolett.4c0414710.1021/acs.nanolett.4c04147 ↗
18. 10.1126/sciadv.adl433610.1126/sciadv.adl4336 ↗
19. 10.1002/adma.20240901510.1002/adma.202409015 ↗
20. 10.1016/j.nantod.2024.10228710.1016/j.nantod.2024.102287 ↗
21. 10.1039/D2SC05848K10.1039/D2SC05848K ↗
22. 10.1039/D0CS00258E10.1039/D0CS00258E ↗
23. 10.1016/j.jconrel.2020.01.05610.1016/j.jconrel.2020.01.056 ↗
24. 10.1002/anie.20191497010.1002/anie.201914970 ↗
25. 10.1016/j.jconrel.2023.01.06410.1016/j.jconrel.2023.01.064 ↗
26. 10.31635/ccschem.024.20240491710.31635/ccschem.024.202404917 ↗
27. 10.1021/acs.nanolett.1c0303110.1021/acs.nanolett.1c03031 ↗
28. 10.3390/cancers1502037610.3390/cancers15020376 ↗
29. 10.3390/cancers1309205310.3390/cancers13092053 ↗
30. 10.3390/metabo1010041210.3390/metabo10100412 ↗
31. 10.1007/s10555-019-09799-010.1007/s10555-019-09799-0 ↗
32. 10.1007/978-94-007-7359-2_1110.1007/978-94-007-7359-2_11 ↗
33. 10.1126/sciadv.abj036410.1126/sciadv.abj0364 ↗
34. 10.1002/adhm.20220336210.1002/adhm.202203362 ↗
35. 10.1002/anie.20231403910.1002/anie.202314039 ↗
36. 10.1002/adma.20230291610.1002/adma.202302916 ↗
37. 10.1021/acsnano.4c0760310.1021/acsnano.4c07603 ↗
38. 10.1021/cr200176r10.1021/cr200176r ↗
39. 10.1021/jacs.1c0387510.1021/jacs.1c03875 ↗
40. 10.1002/anie.20200536210.1002/anie.202005362 ↗
41. 10.1021/jm101541x10.1021/jm101541x ↗
42. 10.1039/c0cc02707c10.1039/c0cc02707c ↗
43. 10.1097/COC.000000000000069110.1097/COC.0000000000000691 ↗
44. 10.1021/jacsau.3c0024110.1021/jacsau.3c00241 ↗
45. 10.1016/j.molstruc.2023.13569710.1016/j.molstruc.2023.135697 ↗
46. 10.1021/acsomega.1c0555410.1021/acsomega.1c05554 ↗
47. 10.31635/ccschem.022.20220209810.31635/ccschem.022.202202098 ↗
48. 10.1016/j.cell.2015.03.02810.1016/j.cell.2015.03.028 ↗
49. 10.1038/nbt.329810.1038/nbt.3298 ↗
50. 10.1021/acsnano.8b0548210.1021/acsnano.8b05482 ↗
51. 10.1073/pnas.92.16.729710.1073/pnas.92.16.7297 ↗
52. 10.1021/cr500542t10.1021/cr500542t ↗
53. 10.1038/mt.2009.28110.1038/mt.2009.281 ↗
54. 10.1016/j.actbio.2022.12.06110.1016/j.actbio.2022.12.061 ↗
55. 10.1039/D5MD00320B10.1039/D5MD00320B ↗
56. 10.1039/D3CS00171G10.1039/D3CS00171G ↗
57. 10.1021/jacs.2c0722510.1021/jacs.2c07225 ↗
58. 10.1039/D1SC03932F10.1039/D1SC03932F ↗
59. 10.1021/acs.analchem.2c0188510.1021/acs.analchem.2c01885 ↗
60. 10.1002/adma.20240042510.1002/adma.202400425 ↗
61. 10.1038/s41551-021-00701-410.1038/s41551-021-00701-4 ↗
62. 10.1002/advs.20220017310.1002/advs.202200173 ↗
63. 10.1002/anie.20231853310.1002/anie.202318533 ↗
64. 10.1016/j.expneurol.2005.08.03010.1016/j.expneurol.2005.08.030 ↗
65. 10.1158/2326-6066.CIR-18-065710.1158/2326-6066.CIR-18-0657 ↗
66. 10.1021/acs.molpharmaceut.3c0004510.1021/acs.molpharmaceut.3c00045 ↗
67. 10.1038/s41416-020-0804-z10.1038/s41416-020-0804-z ↗
68. 10.1039/C5OB00715A10.1039/C5OB00715A ↗
69. 10.1021/acsmedchemlett.7b0028010.1021/acsmedchemlett.7b00280 ↗
70. 10.3390/molecules2305104510.3390/molecules23051045 ↗